Cardiologia Italiana del Territorio

Novità’ dalla letteratura

//Novità’ dalla letteratura
- 04/2016

Clinical Diagnosis of Electrical vs Anatomic Left Ventricular Hypertrophy

aprile 2016|News, Novità’ dalla letteratura|0 Comments

Most physician readers of Aro’s and Chugh’s elegant review of electrical and anatomic types of LVH and the implications will be puzzled by the concepts that electrical LVH (ECG/LVH) and anatomic LVH (echo/LVH and MRI/LVH) might be different entities, and that patients may have one form without the other. These concepts have been evolving over

- 04/2016

Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure

aprile 2016|Cardiologia: presente e futuro... Discutiamone, News, Novità’ dalla letteratura|0 Comments

Patients with heart failure have a poor prognosis, yet outcomes might be improved by early identification of risk. Proenkephalin (proENK), a novel biomarker, is a stable surrogate marker for endogenous enkephalins and is an independent predictor of heart failure and death in patients who had an acute myocardial infarction. This is the first study to

- 03/2016

Parere positivo Fda all’antiaggregante vorapaxar dopo un infarto del miocardio.

marzo 2016|News, Novità’ dalla letteratura|0 Comments

Dopo l’endorsement dei giorni scorsi ricevuto dello staff interno dell’Fda, lo scorso 15 gennaio il nuovo antiaggregante orale vorapaxar ha ricevuto il parere positivo  degli esperti del Cardiovascular and Renal Drugs Advisory Committee dell’Fda. Con 10 voti a 1, gli esperti ne hanno raccomandato l’approvazione come terapia antiaggregante aggiuntiva a quella standard (ASA o ASA

- 02/2016

Long-Term Outcome of Incomplete Revascularization After PCI

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Objectives  The aim of this study was to describe current practice regarding completeness of revascularization in patients with multivessel disease undergoing percutaneous coronary intervention (PCI) and to investigate the association of incomplete revascularization (IR) with death, repeat revascularization, and myocardial infarction (MI) in a large nationwide registry. Background  The benefits of multivessel PCI are controversial.

- 02/2016

Allopurinol and Cardiovascular Outcomes in Adults With Hypertension

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Allopurinol lowers blood pressure in adolescents and has other vasoprotective effects. Whether similar benefits occur in older individuals remains unclear. We hypothesized that allopurinol is associated with improved cardiovascular outcomes in older adults with hypertension. Data from the United Kingdom Clinical Research Practice Datalink were used. Multivariate Cox-proportional hazard models were applied to estimate hazard

- 02/2016

Convention Consensus Document Intersocietaria

febbraio 2016|News, Novità’ dalla letteratura, Senza categoria|0 Comments

Si è concluso Giovedì 4 Febbraio il “Convention Consensus Document Intersocietaria”, tenutosi a Catania su iniziativa dell’A.N.M.C.O., che ha visto riunite le più importanti società scientifiche di area medica, di farmacologia, di biochimica clinica e di biologia molecolare clinica, per condividere la realizzazione del primo Documento Scientifico di Consenso Intersocietario Pluridisciplinare sulle dislipidemie. Con il

- 02/2016

Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Background  Diagnosed diabetes mellitus (DM) is a consistently documented risk factor for ischemic stroke in patients with atrial fibrillation (AF). Objectives  The purpose of this study was to assess the association between duration of diabetes and elevated hemoglobin A1c (HbA1c) with risk of stroke among diabetic patients with AF. Methods  We assessed this association in the ATRIA

- 02/2016

Meta-Analysis of Risks for Short-Term Readmission in Patients With Heart Failure

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

This investigation sought to quantify the risk factors for short-term readmission in patients with heart failure (HF). Electronic databases were systematically searched for studies reporting relative risk, odds ratio, and hazard ratio for the combined primary outcome of all-cause hospital readmission or all-cause mortality ≤90 days from discharge of patients with HF. Clinical characteristics, study design,

- 02/2016

Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study)

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Adiponectin is a key component in multiple metabolic pathways. Studies evaluating associations of adiponectin with clinical outcomes in older adults have reported conflicting results. We investigated the association of adiponectin with mortality and cardiovascular disease (CVD) morbidity in a young, multiethnic adult population. We analyzed data from participants in the Dallas Heart Study without baseline

- 01/2016

Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations

gennaio 2016|News, Novità’ dalla letteratura|0 Comments

The American Journal of Cardiology Alcohol use, physical activity, diet, and cigarette smoking are modifiable cardiovascular risk factors that have a substantial impact on the risk of myocardial infarction, stroke, and cardiovascular death. We hypothesized that these behaviors may alter concentrations of cardiac troponin, a marker of myocyte injury, and B-type natriuretic peptide, a marker